Recombinant attenuated salmonella enterica as a delivery system of heterologous molecules in cancer therapy

HIGHLIGHTS

• who: Elayne Irene Becerra-Báez and collaborators from the Gomez, Mexico have published the paper: Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy, in the Journal: Cancers 2022, 14, 4224. of /2022/
• what: This activity has been evaluated in different preclinical and clinical studies . This activity has been evaluated in several several cancer models, for instance: (a) murine cancer models, including sarcomas , cancer models, for instance: (a) murine cancer models, including sarcomas , leukemia leukemia , colon cancer , prostate cancer , T-cell metastatic lymphoma , , colon cancer , prostate cancer , T-cell . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.